About
Harry Glorikian is a General Partner at Scientia Ventures and a Research Affiliate at the MIT Media Lab, with over three decades of experience building, investing in, and advising companies across healthcare, life sciences, and data-driven technology. He previously served as an Entrepreneur-in-Residence at GE Ventures' New Business Creation Group, where he co-founded Evidation Health and DrawBridge Health, and earlier co-founded and led Scientia Advisors, which Precision for Medicine acquired in 2012. He is the author of four books and hosts a podcast on AI and the data-driven transformation of healthcare, and holds an MBA from Boston University and a bachelor's degree from San Francisco State University.
Contact· published on Harry's own website
Invests in
AI & Machine LearningBiotechDigital HealthHealthtech
Experience
- Scientia VenturesGeneral Partnercurrent2016 — presentUnited States
- MIT Media LabResearch Affilatecurrent2025 — presentCambridge, Massachusetts, United States
- The Harry Glorikian ShowHost of The Harry Glorikian Showcurrent2018 — presentLexington, Massachusetts, United States
- Collective EquityAdvisorcurrent2025 — presentLondon Area, United Kingdom
- Northeastern UniversityMember of Northeastern University Bioengineering Industrial Advisory Board2022 — 2026Boston, Massachusetts, United States
- Beth Israel Deaconess Medical CenterMember of Industry Advisory Committee2020 — 2026Boston, Massachusetts, United States
- StageZero Life SciencesMember Board of Directors2008 — 2026Greater Toronto Area, Canada
- Consilience aiCo-Founder and CEO2021 — 2025United States
- BiocartisBoard Of Directors2018 — 2020Belgium
- Drawbridge HealthAdvisor and Co-Founder2015 — 2020
- Evidation HealthAdvisory Board2015 — 2018Menlo Park, CA
- CibusMember Board of Advisors2012 — 2017San Diego County, California, United States
- CepheidStrategic Advisory Board Member2014 — 2016Sunnyvale, CA
- GE Ventures, New Business CreationEntrepreneur in Residence2014 — 2016Boston/Menlo Park
- DraperMember, Biomedical Advisory Board2006 — 2015Cambridge, MA
- Precision For MedicineSenior Advisor2014Cambridge, MA
- Precision For MedicineManaging Director2012 — 2014Cambridge, MA
- Scientia AdvisorsManaging Partner2004 — 2014Cambridge, MA
- Applied BiosystemsSenior Manager, Business Development1997 — 2004Framingham, MA
- Signet LaboratoriesNational Sales Manager1994 — 1997Dedham, MA
- X-Cell LaboratoriesCo-Founder1993 — 1994San Francisco Bay Area
- BioGenex LaboratoriesSales & Marketing Manager1990 — 1993San Ramon, CA
Skills & more
Digital HealthPrecision MedicineHealthcare InnovationArtificial Intelligence (AI)Biotechnology99Start-ups99Commercialization99Medical Devices99Life Sciences99Entrepreneurship88Technology Transfer67Management Consulting69
+12 more
Product ManagementBusiness StrategyGenomicsR&DProduct DevelopmentMolecular BiologyHealthcareOncologyStrategic PlanningStrategy DevelopmentNegotiationMarket AnalysisLanguages Armenian · Italian
- THE TRAIN THE TRAINER IN PERSON WORKSHOP — Vjal Institute
From Harry's professional profile.
Deals · 1
GenenewsBoard seat
via Scientia Ventures · filed Jul 2017 · $245.6K raise
Attribution from SEC filings, press coverage, and firm rosters.
Colleagues at Scientia Ventures
Daniel Goldman
General Counsel at Scientia Ventures
Dave Schippers
Director of Fund Operations at Scientia Ventures
Joel Dudley
Advisor at Scientia Ventures
John Dessouki
Principal at Scientia Ventures
John Elder
Advisor at Scientia Ventures
Jonathan Finn
General Partner at Scientia Ventures
Mark Finn
General Partner at Scientia Ventures
Omino Gardezi
Advisor at Scientia Ventures
Frequently asked questions
- Who is Harry Glorikian?
- Harry Glorikian is a General Partner at Scientia Ventures and a Research Affiliate at the MIT Media Lab, with over three decades of experience building, investing in, and advising companies across healthcare, life sciences, and data-driven technology. He previously served as an Entrepreneur-in-Residence at GE Ventures' New Business Creation Group, where he co-founded Evidation Health and DrawBridge Health, and earlier co-founded and led Scientia Advisors, which Precision for Medicine acquired in 2012. He is the author of four books and hosts a podcast on AI and the data-driven transformation of healthcare, and holds an MBA from Boston University and a bachelor's degree from San Francisco State University.
- Where does Harry Glorikian work?
- Harry Glorikian is General Partner at Scientia Ventures.
- What does Harry Glorikian invest in?
- Harry Glorikian invests in AI & Machine Learning, Biotech, Digital Health, Healthtech.
- What boards does Harry Glorikian sit on?
- Harry Glorikian holds tracked board seats at Genenews.
- Where did Harry Glorikian go to school?
- Harry Glorikian studied at Boston University (MBA); San Francisco State University (BA, Biology).
Same school
Also attended Boston University334
Aydin SenkutFounder & Managing Partner at FelicisVinnie LauriaFounding Partner at Golden Gate VenturesJeff GrammerPartner at Rho VenturesJoe HayesInvestor at LightbankGil GorenPartner at 83NorthJames LindenbaumCo-founder at Heavybit
+ 328 more
Also attended San Francisco State University120
Dana ChamorroVice President, Technology at Redpoint VenturesJeff BrodyCo-Founder at Redpoint VenturesJulie WalkerInvestor at True VenturesEmily RabbittInvestor at True VenturesStephanie WatkinsOperations at 8VCIndra HusfeldOffice and Finance Coordinator at Sierra Ventures
+ 114 more
